Characterization of bradykinin-induced endothelium-independent contraction in equine basilar artery. 2009

D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
Department of Veterinary Pharmacology, Faculty of Agriculture, Kagoshima University, Korimoto, Kagoshima, Japan.

We investigated the effect of bradykinin (BK) on isolated equine basilar arterial rings with and without endothelium. BK induced concentration-dependent contraction of resting arterial rings and no relaxation when the rings were precontracted by prostaglandin F(2alpha). The maximal response and pD(2) value were 161.2 +/- 28.1% (to 60 mm KCl-induced contraction) and 8.24 +/- 0.25 respectively. The cumulative concentration-response curve for BK was not shifted to the right by des-Arg(9)-[Leu(8)]-BK (a B(1)-receptor antagonist), HOE140 (a B(2)-receptor antagonist) or NPC567 (another B(2)-receptor antagonist). In four of six basilar arteries, NPC567 induced concentration-dependent contraction. Indomethacin (a cyclooxygenase inhibitor), nordihydroguaiaretic acid (a lipoxygenase inhibitor), quinacrine (a phospholipase A(2) inhibitor), tetrodotoxin (a selective blocker of Na(+) channels), guanethidine (a nor-adrenergic neuron blocking drug), phentolamine (an alpha-adrenoceptor antagonist), Nomega-nitro-L-arginine (L-NNA, a nitric oxide (NO) synthase inhibitor) and endothelial denudation did not affect the BK-induced contraction. L-NNA and indomethacin induced contraction and relaxation under resting vascular tone respectively. These results suggest that endothelial cells are not involved in BK-induced contraction and that the contraction is not mediated via activation of known B(1) and B(2) receptors. Arachidonic acid metabolites and neurotransmitters like norepinephrine and NO might not play a role in BK-induced contraction in equine basilar artery.

UI MeSH Term Description Entries
D008297 Male Males
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000003 Abattoirs Places where animals are slaughtered and dressed for market. Slaughterhouses,Slaughter House,Slaughter Houses,Abattoir,House, Slaughter,Houses, Slaughter,Slaughterhouse
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001488 Basilar Artery The artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries. Arteries, Basilar,Artery, Basilar,Basilar Arteries
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
August 1987, European journal of pharmacology,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
December 1988, The Journal of pharmacology and experimental therapeutics,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
April 1989, British journal of pharmacology,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
September 2014, Journal of cardiovascular pharmacology,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
November 1988, The Journal of pharmacology and experimental therapeutics,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
January 1995, Journal of cardiovascular pharmacology,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
May 2002, Naunyn-Schmiedeberg's archives of pharmacology,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
April 1991, Biochemistry international,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
March 2000, British journal of pharmacology,
D Ueno, and A Yabuki, and T Obi, and M Shiraishi, and A Nishio, and A Miyamoto
July 1990, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!